LIVE NOW:Watch the Definedge Conference on Market Analysis (DECMA). Join Now
you are here: HomeNewsBusiness

COVID-19 epidemic in UK shrinking, R-rate estimated below 1

The number of new infections across Britain is shrinking by between 0% and 2% every day, the UK Government Office for Science said, after it was estimated to be growing between 0% and 2% in last week's release.

November 27, 2020 / 10:24 PM IST

The COVID-19 epidemic in Britain has retreated slightly, with the reproduction "R" number estimated to be below 1, suggesting that England's second national lockdown is stemming infections, government scientists said on Friday.

The number of new infections across Britain is shrinking by between 0% and 2% every day, the UK Government Office for Science said, after it was estimated to be growing between 0% and 2% in last week's release.

COVID-19 impact | UK plunges into deep recession, Rishi Sunak warns people of 'hard times' 

The R number was estimated to be between 0.9 and 1, meaning every 10 people infected will go on to infect between 9 and 10 people, down from last week's range of 1.0-1.1.

Government scientists said the estimates were based on latest data for the United Kingdom up to Nov. 24, but that lags meant the impact of national restrictions introduced in England on Nov. 5 were only just being seen and could not yet be fully evaluated.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"R estimates for England may continue to decline in the future and may be below 1 for all regions already," the Government Office for Science said in a statement.

The lockdown in England – home to around 85% of the UK's total population – expires on Wednesday and will be replaced with a regional system of tiered restrictions.

SOME CHRISTMAS CHEER

A third of England is facing the strictest COVID curbs after the previous tier system – imposed before the lockdown – failed to keep infection rates down. That resulted in Prime Minister Boris Johnson announcing the latest England-wide lockdown on Oct. 31.

The stricter tier system comes ahead of a planned loosening of rules for Christmas, when three households will be able to come together indoors over a period of five days.

While the scientists' advice to relax rules for no longer than a week – and focus on limiting household bubbles and not just numbers of contacts – is being followed, a note from the government pandemic modelling subgroup SPI-M-O said the loosening of rules over the Christmas period still posed risks.

"Any relaxation over the festive period will result in increased transmission and increased prevalence, potentially by a large amount," it said in a final version of a note dated Nov. 18 and published on Friday.
Reuters
first published: Nov 27, 2020 10:24 pm

stay updated

Get Daily News on your Browser
Sections